申请人:Ono Pharmaceutical Co., Ltd.
公开号:US05017610A1
公开(公告)日:1991-05-21
A derivative of general formula: ##STR1## wherein Y is --SO.sub.2 -- or ##STR2## (i) R.sup.1 and R.sup.2, which may be the same or different, each represent, (1) --H, (2) C1-16 alkyl or (3) the formula: --X-- .circle.A --(R.sup.4).sub.n wherein X is a single-bond, --SO.sub.2 --, C1-4 alkylene, C1-4 alkylene substituted by ##STR3## -- .circle.A -- is carbocyclic or heterocyclic ring, n is 1.about.5, R.sup.4 is (1) --H or C1-8 alkyl, (2) C1-14 alkoxy, (3) C1-6 alkylthio, (4) --OH, halogen, --NO.sub.2 or trihalomethyl, (5) the formula: --NR.sup.41 R.sup.42 wherein R.sup.41 and R.sup.42 each represents halogen or C1-4 alkyl, (6) tetrazole, (7) --SO.sub.3 H or --CH.sub.2 OH, (8) the formula: --SO.sub.2 NR.sup.41 R.sup.42 (9) the formula: --Z.sup.41 --COOR.sup.43 wherein Z.sup.41 is single-bond, C1-4 alkylene or C2-4 alkenylene, R.sup.43 is --H, C1-4 alkyl or benzyl, (10) the formula: --CONR.sup.41 R.sup.42 (11) the formula: --COO--Z.sup.42 --COOR.sup.43 wherein Z.sup.42 is C1-4 alkylene, R.sup.43 is --H, C1-4 alkyl or benzyl, (12) the formula: --COO--Z.sup.42 --CONR.sup.41 R.sup.42 (13) the formula: --OCO--R.sup.45 wherein R.sup.45 is C1-8 alkyl or p-guanidinophenyl, (14) the formula: --CO--R.sup.46 wherein R.sup.46 is C1-4 alkyl, (15) the formula: --O--Z.sup.43 --COOR.sup.450 wherein Z.sup.43 is C1-6 alkylene, R.sup.450 represents a hydrogen, C1-8 alkyl or p-guanidinophenyl, (16) the formula: ##STR4## wherein ##STR5## is an amino acid residue, R.sup.47 is bond, C1-4 alkyl, R.sup.48 is --H or C1-4 alkyl, R.sup.49 is --OH, C1-4 alkoxy, --NH.sub.2, amino substituted by one or two C1-4 alkyl, carbamoylmethoxy or carbamoylmethoxy substituted by one or two C1-4 alkyl at N atom of carbamoyl, wherein ##STR6## is C3-6 heterocyclic ring, (ii) R.sup.1, R.sup.2 and N atom bonded to R.sup.1 and R.sup.2 together represents heterocyclic ring containing at least a N atom(s) and substituted by --COOH or unsubstituted heterocyclic ring containing at least a N atom(s), R.sup.3 is (1) --H, (2) --OH, (3) C1-6 alkyl, (4) halogen, (5) C1-4 alkoxy or (6) C2-5 acyloxy, m is 1-4. or non-toxic salt or an acid addition salt thereof possess inhibitory activity on elastase, and therefore is useful for treating and/or preventing agent for pulmonary emphysema, atherosclerosis and rheumatoid arthritis and the like.
通用公式的衍
生物:其中Y为--SO.sub.2 --或##STR2## (i) R.sup.1和R.sup.2,可以相同也可以不同,每个代表,(1) --H,(2) C1-16烷基或(3)公式:--X-- .circle.A --(R.sup.4).sub.n,其中X为单键,--SO.sub.2 --,C1-4烷基烯,C1-4烷基烯被##STR3##取代,-- .circle.A --为碳环或杂环,n为1到5,R.sup.4为(1) --H或C1-8烷基,(2) C1-14烷氧基,(3) C1-6烷基
硫,(4) --OH,卤素,--NO.sub.2或三卤甲基,(5)公式:--NR.sup.41 R.sup.42,其中R.sup.41和R.sup.42各自代表卤素或C1-4烷基,(6)
四唑,(7) --SO.sub.3 H或--CH.sub.2 OH,(8)公式:--SO.sub.2 NR.sup.41 R.sup.42,(9)公式:--Z.sup.41 --COOR.sup.43,其中Z.sup.41为单键,C1-4烷基烯或C2-4烯烃,R.sup.43为--H,C1-4烷基或苄基,(10)公式:--CONR.sup.41 R.sup.42,(11)公式:--COO--Z.sup.42 --COOR.sup.43,其中Z.sup.42为C1-4烷基烯,R.sup.43为--H,C1-4烷基或苄基,(12)公式:--COO--Z.sup.42 --CONR.sup.41 R.sup.42,(13)公式:--OCO--R.sup.45,其中R.sup.45为C1-8烷基或p-
胍基苯基,(14)公式:--CO--R.sup.46,其中R.sup.46为C1-4烷基,(15)公式:--O--Z.sup.43 --COOR.sup.450,其中Z.sup.43为C1-6烷基烯,R.sup.450代表氢,C1-8烷基或p-
胍基苯基,(16)公式:##STR4## 其中##STR5##是
氨基酸残基,R.sup.47为键,C1-4烷基,R.sup.48为--H或C1-4烷基,R.sup.49为--OH,C1-4烷氧基,--NH.sub.2,
氨基被一个或两个C1-4烷基取代,羰酰甲氧基或羰酰甲氧基在羰酰的N原子上被一个或两个C1-4烷基取代,其中##STR6##是C3-6杂环,(ii) R.sup.1,R.sup.2和与R.sup.1和R.sup.2结合的N原子共同代表含有至少一个N原子的杂环,该杂环被--COOH或含有至少一个N原子的未取代杂环取代,R.sup.3为(1) --H,(2) --OH,(3) C1-6烷基,(4) 卤素,(5) C1-4烷氧基或(6) C2-5酰氧基,m为1-4。或其无毒盐或酸加成盐具有对
弹性蛋白酶的抑制活性,因此对治疗和/或预防肺气肿、动脉粥样硬化和类风湿性关节炎等疾病有用。